← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 8.9% to $10.29B, while Net income decreased 32.8% to $88.2M.
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $10.29BOK
- Profitability — Net income $88.2MOK
- Cash generation — Free cash flow $293.0MOK
- Accounting — Formula-grey distress score · manipulation and earnings-quality screens not computedNote
- Insiders — 0 buys; 2 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Business
Cushman & Wakefield Ltd.: Our business is focused on meeting the increasing demands of our clients through comprehensive global offerings including (i) Services, (ii) Leasing, (iii) Capital markets and (iv) Valuation and other services.
Where the revenue comes from
Fiscal 2025, as Cushman & Wakefield Ltd. reports it. History and quarterly detail are in the app.
- Americas$7.5B
- APAC$1.7B
- EMEA$1.1B
Leadership changes
From Cushman & Wakefield Ltd.'s own filings, the day they're filed.
- Stephen D. Plavin · director · appointmenteff. 2025-10-01
- Susan Daimler · director · appointmenteff. 2025-08-01
- Brett White · directors · departureeff. 2025-07-31
Latest filings
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-06-15
- 8-K · Company announcement2026-06-04
- 8-K · Company announcement2026-05-15
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Cushman & Wakefield Ltd., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.